A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

ClinicalTrials.gov ID: NCT05897320

Public ClinicalTrials.gov record NCT05897320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 5, 2026, 1:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.

Study identification

NCT ID: NCT05897320
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: H. Lundbeck A/S; Industry
Enrollment: 315 participants

Conditions and interventions

Conditions

Episodic Migraine

Interventions

Eptinezumab Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 6 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 8, 2023 (Actual)
Primary completion: Jul 6, 2027 (Estimated)
Completion: Aug 31, 2027 (Estimated)
Last update posted: Oct 14, 2026

2023 – 2027

United States locations

U.S. sites: 15
U.S. states: 12
U.S. cities: 15

Facility	City	State	ZIP	Site status
New England Institute for Clinical Research (NEICR) - Stamford	Stamford	Connecticut	06905-1206	Recruiting
Child Neurology Center (CNC) of Northwest Florida	Gulf Breeze	Florida	32561-4458	Recruiting
AGA Clinical Trials	Hialeah	Florida	33012-3407	Recruiting
University of South Florida (USF) - Tampa Campus	Tampa	Florida	33620	Recruiting
Clinical Integrative Research Center of Atlanta (CIRCAtl)	Atlanta	Georgia	30328-5574	Completed
UK HealthCare-Kentucky Clinic	Lexington	Kentucky	40536	Completed
University of Maryland School of Medicine	Baltimore	Maryland	21201-1509	Completed
Michigan Headache & Neurological Institute (MHNI)	Ann Arbor	Michigan	48104-5131	Completed
True North Neurology - Commack (North Suffolk Neurology)	Commack	New York	11725-2850	Completed
OnSite Clinical Solutions, LLC - Charlotte	Charlotte	North Carolina	28210-0106	Completed
Akron Children's Hospital	Akron	Ohio	44308-1062	Recruiting
Cincinnati Children's Hospital Medical Center-Burnet Campus	Cincinnati	Ohio	45229-3026	Recruiting
Road Runner Research (RRR)	San Antonio	Texas	78249-3539	Recruiting
Children's Specialty Group (CSG)	Norfolk	Virginia	23507	Recruiting
Children's Wisconsin (Children's Hospital of Wisconsin)-Main Campus	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05897320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 14, 2026 · Synced Nov 5, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05897320 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →